“Health Outcomes”

21 result(s)
Care Management
The Rise of GLP-1s to Improve Metabolic Health
New CVS Caremark white paper describes the reasons for the rapid increase in utilization of GLP-1 drugs to treat diabetes and obesity. More
Briefing
Cost Management
Next in Gene Therapy: 2024 Roundup
An update on the gene therapy pipeline More
Briefing
Care Management
Metabolism Matters: Building a Blueprint for Improved Outcomes
Diabetes and obesity result from poor metabolic health and are associated with more than 200 chronic diseases. Focusing on metabolic health can help to improve health status... More
Briefing
Cost Management
Gene Therapy for Sickle Cell Disease
Gene therapy to treat sickle cell disease could soon be a reality More
Briefing
Cost Management
Considering the complexities and cost of radiation oncology
Strategies for delivering more efficient and effective care that costs less More
Briefing
Care Management
Improve GLP-1 effectiveness for weight loss with condition management
Drive sustainable member behavior change for better health outcomes and cost savings More
Briefing
Cost Management
A Balanced Approach to Weight Management Drugs
Strategies for balancing coverage and spend for high-cost diabetes and obesity medications More
Briefing
Drug Pipeline
Protecting Infants and Young Children from RSV
Protecting Infants and Young Children from RSV More
Briefing
Drug Pipeline
Non-Alcoholic Steatohepatitis on the Rise Around the World
Non-Alcoholic Steatohepatitis on the Rise Around the World More
Briefing
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline More
Briefing